Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 110.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 56,952
  • Market Cap: £116.85m
  • RiskGrade: 258

London close: Late rally not enough

Date: Tuesday 17 Mar 2009

  • Market Movers
  • techMARK 1,139.77 -0.44%
  • FTSE 100 3,857.10 -0.18%
  • FTSE 250 6,211.79 -0.93%

LONDON (ShareCast) - Footsie spent much of the day trying to lift itself into the blue but finished slightly lower even after rallying on the back of a strong showing on Wall Street.

Miners were among the heaviest fallers, amid a backdrop of weak metals prices. Kazakhstan’s ENRC fell nearly 10%, while Rio Tinto, which appointed British American Tobacco chairman Jan du Plessis to also act as its chairman, also lost value.

Oil heavyweight Royal Dutch Shell was a drag on the index after the group’s trading update. The group said it has balance sheet flexibility to maintain investment and grow dividends in the downturn and to fund future growth projects. The company also revealed it is being investigated by US Securities and Exchange Commission for possible breaches of bribery rules.

Shell’s value is also hit by the lower oil price, which is usually good news for Carnival, but the cruise operator fell back after seeing its price target cut at RBS. The broker is worried that low bookings in January will affect the company’s results next week. Carnival did recover slightly but still finished in the red.

Caterer Compass was also hit by unfavourable broker coverage, with Deutsche Bank moving the stock to ‘hold’ from ‘sell’ after a share price rally.

Life and pensions group Friends Provident reported full-year underlying profits in line with expectations and said it expects new business in early 2009 to be below the 2008 comparatives.

Department store chain Debenhams fell sharply after it said first half pre-tax profit will be ahead of previous year but there was no mention of the cash-call expected by some. The group said the combined impact of higher gross transaction value, gross margin and tight management of costs will result in first half profit before tax and EBITDA being ahead of the previous year.

JJB Sports has agreed a further extension of the standstill arrangements with its lenders and confirmed it is considering a company voluntary arrangement to help it ease some of its crippling debt problems.

Thomas Cook Group climbs after it said Karl-Gerhard Eick will succeed Thomas Middelhoff as non-executive chairman with immediate effect. Eick joined the Thomas Cook board in December 2008 as an Arcandor nominated non-executive director.

Component distributor Diploma has warned that a tough time for its seals business in the US and the adverse effects of the pound's weakness have hit both sales and profits in the past six months.

Higher production volumes and commodity prices pushed Venture Production profits up 82% in the year. Pre-tax profit rose to £184.2m from £101.2m last year as revenue rose 38% to £494.9m thanks to substantially higher oil prices especially in the first half of the year and strong UK gas markets.

Torotrak surged forward as Allison Transmission, the world leader in fully automatic transmissions for commercial vehicles, took a 10% stake at 16.5p per share and purchased technology rights for £8.4m.

Kirkland Lake Gold is upbeat after third quarter losses narrowed slightly from the previous quarter and as it sits on a pile of cash to fund mining operations in Canada.

Broadband and telecom systems company BATM Advanced Communications revealed a 20% increase in annual pre-tax profit but investors were disappointed and the shares fell back. The company said it is 'cautiously optimistic' about prospects for this year and beyond.

AIM-listed marketing services group Cello saw profits slip slightly for the year but said it has made a “solid start” to the new year. Pre-tax profits fell to £2.8m from £3.1m before on revenue that rose to £139.1m from £108.3m previously.

Stockbroker Collins Stewart gave up ground Tuesday after restructuring costs and a series of write-downs sent it plunging into the red in 2008. The former bid target lost £15.2m before tax in the year ended 31 December 2008 versus a £79m profit the year before. Revenue dived 25% to £175.7m and to £187.8m on an adjusted basis.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 110.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.50
52 Week Low 101.00
Volume 56,952
Shares Issued 106.23m
Market Cap £116.85m
RiskGrade 258

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.69% below the market average64.69% below the market average64.69% below the market average64.69% below the market average64.69% below the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Price Trend
21.22% above the market average21.22% above the market average21.22% above the market average21.22% above the market average21.22% above the market average
12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average
Income
26.26% below the market average26.26% below the market average26.26% below the market average26.26% below the market average26.26% below the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average
Growth
39.24% below the market average39.24% below the market average39.24% below the market average39.24% below the market average39.24% below the market average
38.89% below the sector average38.89% below the sector average38.89% below the sector average38.89% below the sector average38.89% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 09-Apr-2020

Time Volume / Share Price
16:31 25,000 @ 110.00p
16:06 25,000 @ 110.00p
15:57 608 @ 111.64p
15:45 1,897 @ 112.00p
14:39 4,450 @ 109.06p

Cello Health Key Personnel

CEO Mark Scott

Top of Page